These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 20377821

  • 1. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

  • 2. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].
    Hirono N, Kobayashi H, Mori E.
    No To Shinkei; 1998 Jun; 50(6):561-7. PubMed ID: 9656252
    [Abstract] [Full Text] [Related]

  • 3. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N, Tsukamoto N, Inoue M, Moriwaki Y, Mori E.
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [Abstract] [Full Text] [Related]

  • 4. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S, Portet F, Picot MC, Defez C, Pose C, Blayac JP, Touchon J.
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [Abstract] [Full Text] [Related]

  • 5. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):541-5. PubMed ID: 20184936
    [Abstract] [Full Text] [Related]

  • 6. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K, Black S, Bedard MA, Tran T, Lussier I, TOPS Study Investigators.
    Int J Geriatr Psychiatry; 2007 Apr 16; 22(4):312-9. PubMed ID: 17006874
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 16; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 8. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
    Jones RW, Soininen H, Hager K, Aarsland D, Passmore P, Murthy A, Zhang R, Bahra R.
    Int J Geriatr Psychiatry; 2004 Jan 16; 19(1):58-67. PubMed ID: 14716700
    [Abstract] [Full Text] [Related]

  • 9. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M.
    Dement Geriatr Cogn Disord; 2009 Jan 16; 28(3):196-205. PubMed ID: 19738386
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
    Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM, Donepezil MSAD Study Investigators Group.
    Int J Geriatr Psychiatry; 2005 Jun 16; 20(6):559-69. PubMed ID: 15920715
    [Abstract] [Full Text] [Related]

  • 11. The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area.
    Araki T, Wake R, Miyaoka T, Kawakami K, Nagahama M, Furuya M, Limoa E, Liaury K, Hashioka S, Murotani K, Horiguchi J.
    Int J Geriatr Psychiatry; 2014 Sep 16; 29(9):881-9. PubMed ID: 24436135
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A, Gauthier S, Perdomo C.
    Int J Geriatr Psychiatry; 2007 Aug 16; 22(8):806-12. PubMed ID: 17199235
    [Abstract] [Full Text] [Related]

  • 13. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S.
    Neurology; 2007 Jul 31; 69(5):459-69. PubMed ID: 17664405
    [Abstract] [Full Text] [Related]

  • 14. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2008 Jul 31; 25(5):399-407. PubMed ID: 18391486
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
    Dement Geriatr Cogn Disord; 2009 Jul 31; 27(3):232-9. PubMed ID: 19246907
    [Abstract] [Full Text] [Related]

  • 16. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
    Tanaka M, Namiki C, Thuy DH, Yoshida H, Kawasaki K, Hashikawa K, Fukuyama H, Kita T.
    J Neurol Sci; 2004 Oct 15; 225(1-2):135-41. PubMed ID: 15465097
    [Abstract] [Full Text] [Related]

  • 17. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Oct 15; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y, Hashimoto M, Kaneda K, Honda K, Ogawa Y, Yuuki S, Ikeda M.
    Psychogeriatrics; 2013 Jun 15; 13(2):88-93. PubMed ID: 23909965
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P, Tsolaki M, Hort J, Hager K, Soininen H, López Pousa S, Li C, Schwam E.
    Curr Med Res Opin; 2007 Dec 15; 23(12):3153-65. PubMed ID: 17988434
    [Abstract] [Full Text] [Related]

  • 20. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
    Tei E, Yamamoto H, Watanabe T, Miyazaki A, Nakadate T, Kato N, Mimura M.
    Growth Horm IGF Res; 2008 Feb 15; 18(1):47-54. PubMed ID: 17714966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.